Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloJoin Therapy for Knee Osteoarthritis
NCT06570291Phase 3Recruiting
- Sponsor
- WuXi AppTec
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic adipose-derived stromal/stem cells in knee osteoarthritis (OA), sponsored by WuXi AppTec. Started Feb 2025; status: recruiting.
02
Drugs
allogeneic adipose-derived stromal/stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06570291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06570291.